Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Leukemia, Basophilic, Acute

phenylmethylsulfonyl fluoride has been researched along with Leukemia, Basophilic, Acute in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobsson, SO1
Fowler, CJ1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Leukemia, Basophilic, Acute

ArticleYear
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    British journal of pharmacology, 2001, Volume: 132, Issue:8

    Topics: Amides; Animals; Arachidonic Acids; Brain Neoplasms; Cannabinoids; Cell Survival; Endocannabinoids;

2001